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Figure 1   A 32- year old man with arthritis and 
effusion of the left knee
 Haemogram showed haemoglobin of 15.1 gr/
dl, total leucocyte count of 4800/μL), lymphocyte 
of 40%, thrombocyte count of 222,000/μL, ESR 
of 25mm/1st hr, AST of 22 U/L, ALT of 17 U/L, 
urea level of 6.87 mg/dl, creatinine level of (1.06 
mg/dl), serum albumin level of 3.9 g/L, CRP of 
3.74 mg/dl, and CD4 count of 48/mm3. No data 
of knee x-ray and synovial fl uid analysis were 
available.
 Athrocentesis was performed to heal knee 
effusion. Culture of synovial fl uid did not reveal 
aerobic and acid fast bacilli microorganism. The 
patient was treated with duviral (zidovudine 300 
mg + lamivudine 150 mg) b.i.d, efavirenz 200 
mg t.i.d, cotrimoxazole 480 mg two tablets daily 
and paracetamol 500 mg t.i.d. Anti tuberculosis 
drugs of rifampicin 150 mg t.i.d, pyrazynamide 
500 mg t.i.d and ofl oxacine 200 mg b.i.d were 
administered. Pain or effusion in both knees 
was not found a week after aspiration of knee 
effusion.
DISCUSSION
Human immunodefi ciency virus infection is a 
global health problem. The clinical spectrum of 
diseases associated with HIV infection is wide. 
Prevalence of rheumatic manifestations in HIV 
infected patients has been reported ranging 
from less than 1% to more than 60% depending 
on the study method.5,6  The number of CD4+ T 
cells as a predisposing factor for the different 
Human immunodefi ciency virus (HIV)-associated 
arthritis is an oligoarthritis which predominantly 
affect the knees and ankles. It tends to be self-
limited and to last less than six weeks. However, 
some patients with HIV-associated arthritis have 
been reported to have a disease course of more 
than six weeks with joint destruction. Synovial 
fl uid cultures are typically sterile and radiographs 
of the affected joints are usually normal except 
in those rare patients with a prolonged duration 
of symptoms in whom joint-space narrowing can 
occur.1,2  The pathophysiology of HIV specifi c 
arthritis types is not fully understood but drugs 
of the highly active antiretroviral therapy, in 
particular indinavir, are supposed to cause arthritis 
or rheumatological complaints.3 However, 
recently both human T-lymphotropic virus 
(HTLV) type I and HTLV-II have been suggested 
to induce infl ammatory or autoimmune reactions 
which can increase signifi cantly the incidence of 
arthritis.4 We report a patient with HIV infection 
presenting as knee arthritis which was apparently 
not associated with antiretroviral therapy. 
CASE REPORT
A 32 year-old man came to the Rheumatology 
Policlinic of Cipto Mangunkusumo Hospital with 
the chief complaint of pain and swelling of the left 
knee since two weeks ago. He had suffered from 
HIV and Hepatitis C since a year ago. He also had 
lung tuberculosis since eight months ago and was 
treated with anti tuberculosis drugs, but as he was 
allergic to isoniazid and ethambutol, he was given 
a combination of rifampicine, pyrazinamide and 
ofl oxacine. He was given antiretroviral therapy, 
that is, a combination of duviral (zidovudine + 
lamivudine) and efavirenz for two months. He 
had a history of drug abuse fi ve years ago.
 The examination revealed swelling, minimal 
tender joint, and limited range of motion of the 
left knee (fi gure 1). The right knee was normal. 
Cardiopulmonary and neurological examination 
did not fi nd abnormality. Small macular 
hyperpigmentations were found on the skin and 
spread all over his body. This may be caused by 
an allergic reaction to anti tuberculosis drugs.
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musculoskeletal manifestations has not been fully elucidated. 
The exact incidence of manifestation of arthritis in patients 
with HIV remains unclear.7 Even though musculoskeletal 
complications are seen throughout the course of infection, 
they are more common during this later stage. About 75% 
of HIV infected individuals will experience musculoskeletal 
complications during the course of the disease. The majority of 
musculoskeletal manifestations in HIV disease are reactive in 
nature, whether secondary to HIV infection itself, or reactive 
to opportunistic infections elsewhere.8 
 There are two proposed theories about its origin: that it is a 
reaction to immune complexes within the synovium and that it 
is a direct HIV infection of the synovial tissues. An HIV-positive 
assay of an affected patient’s synovial fl uid culture supports 
the theory that direct HIV infection of the synovial tissues is 
responsible for this condition.9 HIV-associated arthritis has an 
overall male preponderance and is characterized by an acute 
onset of severe pain and disability, predominantly in the knees 
and ankles. It is self-limited, usually lasting a few weeks to 
6 months. The synovial fl uid commonly contains only 50 to 
2600 white blood cells/μL.9,10 There were no data of synovial 
fl uid analysis from our patient.
 Apart from these types of arthritis, it has to be taken into 
account that treatment with protease inhibitors, in particular 
indinavir, is associated with rheumatic disorders as well as 
other side effects such as renal calculi, nail disorders, and 
lipodystrophy. A multicentre survey concluded that non-
specifi c joint pain was more often reported by patients on 
a treatment regimen with a protease inhibitor (indinavir, 
nelfi navir, ritonavir-saquinavir combination) than by patients 
with a non-protease inhibitor.3 
 A case of an acute monoarthritis of the left knee resulting 
from a 6 week course of indinavir was reported by Brooks 
et al.11 As no bacterial, viral (apart from HIV infection),or 
fungal cause of arthritis could be demonstrated, intra-articular 
indinavir levels were measured. Although the intra-articular 
indinavir concentration of 1.36 μl/ml was within the serum 
range of 0.2-7.4 μg/ml, they assumed that indinavir crystals, 
analogous to ureate crystals, may occur in the synovial fl uid 
because of the poor solubility of indinavir which varies 
inversely with pH. In our case, a protease inhibitor was not 
given, so that arthritis may be not associated with antiretroviral 
therapy.
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